Your browser doesn't support javascript.
loading
Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c.
Stehling-Sun, Sandra; Dade, Jessica; Nutt, Stephen L; DeKoter, Rodney P; Camargo, Fernando D.
Afiliação
  • Stehling-Sun S; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
Nat Immunol ; 10(3): 289-96, 2009 Mar.
Article em En | MEDLINE | ID: mdl-19169261
ABSTRACT
Despite advances in the identification of lymphoid-restricted progenitor cells, the transcription factors essential for their generation remain to be identified. Here we describe an unexpected function for the myeloid oncogene product Mef2c in lymphoid development. Mef2c deficiency was associated with profound defects in the production of B cells, T cells, natural killer cells and common lymphoid progenitor cells and an enhanced myeloid output. In multipotent progenitors, Mef2c was required for the proper expression of several key lymphoid regulators and restriction of the myeloid fate. Our studies also show that Mef2c was a critical transcriptional target of the transcription factor PU.1 during lymphopoiesis. Thus, Mef2c is a crucial component of the transcriptional network that regulates cell fate 'choice' in multipotent progenitors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Regulação Miogênica / Linfopoese / Células Progenitoras Linfoides Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Regulação Miogênica / Linfopoese / Células Progenitoras Linfoides Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2009 Tipo de documento: Article